

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of chemokine biosynthetic process (GO:0045080) | 6.67615690 |
| 2 | response to peptidoglycan (GO:0032494) | 6.09793062 |
| 3 | modulation by symbiont of host immune response (GO:0052553) | 5.92630275 |
| 4 | positive regulation by symbiont of host defense response (GO:0052509) | 5.92630275 |
| 5 | modulation by symbiont of host defense response (GO:0052031) | 5.92630275 |
| 6 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.92630275 |
| 7 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.92630275 |
| 8 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.92630275 |
| 9 | positive regulation of heat generation (GO:0031652) | 5.68498782 |
| 10 | regulation of fever generation (GO:0031620) | 5.65555027 |
| 11 | regulation of chemokine biosynthetic process (GO:0045073) | 5.51808619 |
| 12 | regulation of T-helper 1 cell differentiation (GO:0045625) | 5.31027955 |
| 13 | neutrophil activation involved in immune response (GO:0002283) | 5.17684243 |
| 14 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 5.16515774 |
| 15 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 5.15715685 |
| 16 | regulation of podosome assembly (GO:0071801) | 4.95659437 |
| 17 | * lipopolysaccharide-mediated signaling pathway (GO:0031663) | 4.79390650 |
| 18 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 4.76534577 |
| 19 | regulation of cytokine secretion involved in immune response (GO:0002739) | 4.66767954 |
| 20 | positive regulation of interferon-alpha production (GO:0032727) | 4.59105187 |
| 21 | regulation of vitamin D biosynthetic process (GO:0060556) | 4.58666836 |
| 22 | regulation of interferon-alpha production (GO:0032647) | 4.47302665 |
| 23 | macrophage activation involved in immune response (GO:0002281) | 4.47008689 |
| 24 | regulation of heat generation (GO:0031650) | 4.35705731 |
| 25 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 4.32090223 |
| 26 | respiratory burst (GO:0045730) | 4.31350308 |
| 27 | regulation of mononuclear cell migration (GO:0071675) | 4.29540604 |
| 28 | hydrogen peroxide biosynthetic process (GO:0050665) | 4.24305065 |
| 29 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.21232296 |
| 30 | regulation of chronic inflammatory response (GO:0002676) | 4.18697854 |
| 31 | cytidine deamination (GO:0009972) | 4.16175729 |
| 32 | cytidine metabolic process (GO:0046087) | 4.16175729 |
| 33 | cytidine catabolic process (GO:0006216) | 4.16175729 |
| 34 | regulation of vitamin metabolic process (GO:0030656) | 4.06564911 |
| 35 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.99076604 |
| 36 | NIK/NF-kappaB signaling (GO:0038061) | 3.98845614 |
| 37 | response to type I interferon (GO:0034340) | 3.98282999 |
| 38 | response to muramyl dipeptide (GO:0032495) | 3.95110288 |
| 39 | superoxide anion generation (GO:0042554) | 3.94243588 |
| 40 | regulation of heterotypic cell-cell adhesion (GO:0034114) | 3.87466318 |
| 41 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.85683800 |
| 42 | response to host immune response (GO:0052572) | 3.85683800 |
| 43 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 3.84978301 |
| 44 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 3.84362893 |
| 45 | immunoglobulin mediated immune response (GO:0016064) | 3.79984283 |
| 46 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 3.79121031 |
| 47 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.78345135 |
| 48 | reactive oxygen species biosynthetic process (GO:1903409) | 3.75596791 |
| 49 | activation of MAPKKK activity (GO:0000185) | 3.75095497 |
| 50 | negative regulation of amino acid transport (GO:0051956) | 3.73941263 |
| 51 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.72722087 |
| 52 | regulation of immunoglobulin secretion (GO:0051023) | 3.72645944 |
| 53 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 3.72462647 |
| 54 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.72246736 |
| 55 | positive regulation of B cell mediated immunity (GO:0002714) | 3.69651119 |
| 56 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 3.69651119 |
| 57 | positive regulation of humoral immune response (GO:0002922) | 3.67515677 |
| 58 | cellular response to interferon-beta (GO:0035458) | 3.62241269 |
| 59 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 3.58717287 |
| 60 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.58086028 |
| 61 | microglial cell activation (GO:0001774) | 3.57284923 |
| 62 | negative regulation of interleukin-17 production (GO:0032700) | 3.56284892 |
| 63 | positive regulation of chemokine production (GO:0032722) | 3.56201763 |
| 64 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 3.51697969 |
| 65 | regulation of growth of symbiont in host (GO:0044126) | 3.51697969 |
| 66 | negative regulation of growth of symbiont in host (GO:0044130) | 3.51697969 |
| 67 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 3.51697969 |
| 68 | negative regulation of viral genome replication (GO:0045071) | 3.49502371 |
| 69 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.49331464 |
| 70 | macrophage activation (GO:0042116) | 3.47919899 |
| 71 | cellular response to nicotine (GO:0071316) | 3.47720613 |
| 72 | positive regulation of nitric oxide biosynthetic process (GO:0045429) | 3.46034943 |
| 73 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 3.45300651 |
| 74 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.44430429 |
| 75 | positive regulation of mast cell degranulation (GO:0043306) | 3.44430429 |
| 76 | defense response to protozoan (GO:0042832) | 3.44261638 |
| 77 | myeloid dendritic cell activation (GO:0001773) | 3.43416257 |
| 78 | regulation of interleukin-17 production (GO:0032660) | 3.42273090 |
| 79 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 3.41647066 |
| 80 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.40870775 |
| 81 | response to host (GO:0075136) | 3.40309600 |
| 82 | response to host defenses (GO:0052200) | 3.40309600 |
| 83 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.40309600 |
| 84 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.39815847 |
| 85 | positive regulation of defense response to virus by host (GO:0002230) | 3.39584251 |
| 86 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.38720975 |
| 87 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.37781025 |
| 88 | positive regulation of interferon-beta production (GO:0032728) | 3.36191614 |
| 89 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 3.35284912 |
| 90 | myeloid dendritic cell differentiation (GO:0043011) | 3.32915601 |
| 91 | leukocyte aggregation (GO:0070486) | 3.32256658 |
| 92 | response to interferon-beta (GO:0035456) | 3.28733657 |
| 93 | cellular response to exogenous dsRNA (GO:0071360) | 3.27941003 |
| 94 | regulation of T-helper 1 type immune response (GO:0002825) | 3.27214997 |
| 95 | positive regulation of lymphocyte apoptotic process (GO:0070230) | 3.26377285 |
| 96 | T-helper 1 type immune response (GO:0042088) | 3.25600126 |
| 97 | * granulocyte activation (GO:0036230) | 3.25190795 |
| 98 | regulation of interleukin-12 production (GO:0032655) | 3.23107395 |
| 99 | neutrophil activation (GO:0042119) | 3.22498139 |
| 100 | * monocyte chemotaxis (GO:0002548) | 3.21602966 |
| 101 | negative regulation of production of molecular mediator of immune response (GO:0002701) | 3.21558606 |
| 102 | positive regulation of interleukin-12 production (GO:0032735) | 3.21314855 |
| 103 | positive regulation of interleukin-6 production (GO:0032755) | 3.20856626 |
| 104 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 3.19836451 |
| 105 | positive regulation of cytokine biosynthetic process (GO:0042108) | 3.19469048 |
| 106 | positive regulation of interleukin-17 production (GO:0032740) | 3.18839194 |
| 107 | negative regulation of interleukin-12 production (GO:0032695) | 3.18493305 |
| 108 | regulation of nitric oxide biosynthetic process (GO:0045428) | 3.17100924 |
| 109 | germinal center formation (GO:0002467) | 3.15196402 |
| 110 | positive regulation of T cell cytokine production (GO:0002726) | 3.14028492 |
| 111 | detection of molecule of bacterial origin (GO:0032490) | 3.13667596 |
| 112 | positive regulation of T-helper 1 type immune response (GO:0002827) | 3.11168248 |
| 113 | * myeloid cell activation involved in immune response (GO:0002275) | 3.11160984 |
| 114 | positive regulation of interleukin-10 production (GO:0032733) | 3.10765336 |
| 115 | positive regulation of type 2 immune response (GO:0002830) | 3.10295152 |
| 116 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.09581460 |
| 117 | cellular response to type I interferon (GO:0071357) | 3.09466586 |
| 118 | type I interferon signaling pathway (GO:0060337) | 3.09466586 |
| 119 | * positive regulation of lymphocyte migration (GO:2000403) | 3.09384321 |
| 120 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 3.08957823 |
| 121 | response to protozoan (GO:0001562) | 3.08423031 |
| 122 | positive regulation of acute inflammatory response (GO:0002675) | 3.07044994 |
| 123 | * regulation of lymphocyte chemotaxis (GO:1901623) | 3.01399862 |
| 124 | * cellular response to lipopolysaccharide (GO:0071222) | 2.99108777 |
| 125 | regulation of T cell tolerance induction (GO:0002664) | 2.99100221 |
| 126 | regulation of NF-kappaB import into nucleus (GO:0042345) | 2.96126302 |
| 127 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.95747716 |
| 128 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 2.94632335 |
| 129 | regulation of viral genome replication (GO:0045069) | 2.91584936 |
| 130 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.90870302 |
| 131 | B cell mediated immunity (GO:0019724) | 2.89197722 |
| 132 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.87381189 |
| 133 | * cellular response to molecule of bacterial origin (GO:0071219) | 2.87000638 |
| 134 | regulation of T-helper cell differentiation (GO:0045622) | 2.84852000 |
| 135 | dendritic cell differentiation (GO:0097028) | 2.84725461 |
| 136 | DNA deamination (GO:0045006) | 2.81340711 |
| 137 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.81125390 |
| 138 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.80237764 |
| 139 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.79692489 |
| 140 | negative regulation of lipid storage (GO:0010888) | 2.78889223 |
| 141 | * negative regulation of viral process (GO:0048525) | 2.77929342 |
| 142 | positive regulation of leukocyte apoptotic process (GO:2000108) | 2.77820411 |
| 143 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.76367829 |
| 144 | * cellular response to interferon-gamma (GO:0071346) | 2.76347772 |
| 145 | oligosaccharide catabolic process (GO:0009313) | 2.69617973 |
| 146 | positive regulation of interferon-gamma production (GO:0032729) | 2.68437216 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 7.14755972 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.77464093 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.29749958 |
| 4 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.27931155 |
| 5 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.96530868 |
| 6 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.95343357 |
| 7 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 3.62654053 |
| 8 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.59131435 |
| 9 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.57953077 |
| 10 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.50272532 |
| 11 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.21159065 |
| 12 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.00107184 |
| 13 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.80387861 |
| 14 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.70662969 |
| 15 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.63820285 |
| 16 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.56448154 |
| 17 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.55097127 |
| 18 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.06074650 |
| 19 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 10.6739388 |
| 20 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.90761058 |
| 21 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.87780148 |
| 22 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.81240932 |
| 23 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.76224340 |
| 24 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.65754754 |
| 25 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.64509640 |
| 26 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.64431233 |
| 27 | * PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.63195558 |
| 28 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.59834733 |
| 29 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.59357547 |
| 30 | * VDR_24787735_ChIP-Seq_THP-1_Human | 1.58310281 |
| 31 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.58300468 |
| 32 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.53001091 |
| 33 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.48108599 |
| 34 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.40684377 |
| 35 | MYB_26560356_Chip-Seq_TH2_Human | 1.39711008 |
| 36 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.36551507 |
| 37 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.34689484 |
| 38 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.34220810 |
| 39 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.30854593 |
| 40 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.27310504 |
| 41 | SPI1_23127762_ChIP-Seq_K562_Human | 1.27222574 |
| 42 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.26126264 |
| 43 | * MAF_26560356_Chip-Seq_TH2_Human | 1.24794864 |
| 44 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.23617139 |
| 45 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.22830901 |
| 46 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.20758372 |
| 47 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.18510541 |
| 48 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.15826990 |
| 49 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.13193997 |
| 50 | * ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.10252237 |
| 51 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.09945715 |
| 52 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.09483992 |
| 53 | MAF_26560356_Chip-Seq_TH1_Human | 1.09460041 |
| 54 | GATA3_26560356_Chip-Seq_TH2_Human | 1.08633055 |
| 55 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.07241922 |
| 56 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.06956984 |
| 57 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.04717000 |
| 58 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.04189038 |
| 59 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.03443203 |
| 60 | MYB_26560356_Chip-Seq_TH1_Human | 1.01651207 |
| 61 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.00914534 |
| 62 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.00738203 |
| 63 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.00738203 |
| 64 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.99699439 |
| 65 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.99484852 |
| 66 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.98866685 |
| 67 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.96984117 |
| 68 | * LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.96567343 |
| 69 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.94754860 |
| 70 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 0.93283467 |
| 71 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.92379628 |
| 72 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.92045589 |
| 73 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.91532460 |
| 74 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.91251151 |
| 75 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.90967900 |
| 76 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 0.90805222 |
| 77 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.90805222 |
| 78 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 0.90805222 |
| 79 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.89839229 |
| 80 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.89450058 |
| 81 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.88451195 |
| 82 | MYC_22102868_ChIP-Seq_BL_Human | 0.87518846 |
| 83 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.85433543 |
| 84 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.84809313 |
| 85 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.84499694 |
| 86 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.83839868 |
| 87 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.83720137 |
| 88 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.83701796 |
| 89 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.80543891 |
| 90 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.78518348 |
| 91 | UTX_26944678_Chip-Seq_JUKART_Human | 0.78041974 |
| 92 | GATA1_19941826_ChIP-Seq_K562_Human | 0.77773194 |
| 93 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.76173939 |
| 94 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.76116185 |
| 95 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.76001515 |
| 96 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.75256213 |
| 97 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.74998928 |
| 98 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.74344214 |
| 99 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.73518074 |
| 100 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.72706133 |
| 101 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.72499270 |
| 102 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.70952770 |
| 103 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.70937557 |
| 104 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.69870828 |
| 105 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.64346021 |
| 106 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.64237633 |
| 107 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.63903639 |
| 108 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.63797213 |
| 109 | CJUN_26792858_Chip-Seq_BT549_Human | 0.63661351 |
| 110 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.62095838 |
| 111 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.60333502 |
| 112 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.59474179 |
| 113 | GATA1_22025678_ChIP-Seq_K562_Human | 0.57512562 |
| 114 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.57484139 |
| 115 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.56003064 |
| 116 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.55622965 |
| 117 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.54998196 |
| 118 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.54714593 |
| 119 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.54692896 |
| 120 | GATA2_19941826_ChIP-Seq_K562_Human | 0.53809580 |
| 121 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.53412185 |
| 122 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.53389573 |
| 123 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.53115470 |
| 124 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.53115470 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0009785_altered_susceptibility_to | 4.81455442 |
| 2 | MP0003436_decreased_susceptibility_to | 4.57359051 |
| 3 | MP0001835_abnormal_antigen_presentation | 4.25639906 |
| 4 | * MP0002148_abnormal_hypersensitivity_rea | 3.99147152 |
| 5 | * MP0006082_CNS_inflammation | 3.94115858 |
| 6 | MP0003303_peritoneal_inflammation | 3.87814866 |
| 7 | MP0003724_increased_susceptibility_to | 3.65159026 |
| 8 | MP0005000_abnormal_immune_tolerance | 3.61231123 |
| 9 | MP0002419_abnormal_innate_immunity | 3.45207654 |
| 10 | * MP0005025_abnormal_response_to | 3.21307029 |
| 11 | MP0005671_abnormal_response_to | 2.90359895 |
| 12 | MP0009764_decreased_sensitivity_to | 2.65484402 |
| 13 | MP0002452_abnormal_antigen_presenting | 2.60986923 |
| 14 | * MP0002723_abnormal_immune_serum | 2.57914669 |
| 15 | MP0001533_abnormal_skeleton_physiology | 2.56936816 |
| 16 | MP0001800_abnormal_humoral_immune | 2.49171830 |
| 17 | MP0001853_heart_inflammation | 2.41856376 |
| 18 | MP0005387_immune_system_phenotype | 2.41259378 |
| 19 | MP0001790_abnormal_immune_system | 2.41259378 |
| 20 | MP0002139_abnormal_hepatobiliary_system | 2.40885839 |
| 21 | MP0004510_myositis | 2.34195011 |
| 22 | MP0004947_skin_inflammation | 2.22301115 |
| 23 | MP0000685_abnormal_immune_system | 2.17543276 |
| 24 | MP0001819_abnormal_immune_cell | 2.17473898 |
| 25 | MP0002420_abnormal_adaptive_immunity | 2.14872967 |
| 26 | MP0005058_abnormal_lysosome_morphology | 2.12800071 |
| 27 | MP0005464_abnormal_platelet_physiology | 2.11038552 |
| 28 | MP0002405_respiratory_system_inflammati | 2.03109557 |
| 29 | MP0001845_abnormal_inflammatory_respons | 1.98407803 |
| 30 | MP0002006_tumorigenesis | 1.96175786 |
| 31 | MP0003075_altered_response_to | 1.95049861 |
| 32 | MP0000343_altered_response_to | 1.91359308 |
| 33 | * MP0008469_abnormal_protein_level | 1.86419833 |
| 34 | MP0009333_abnormal_splenocyte_physiolog | 1.81057697 |
| 35 | MP0003806_abnormal_nucleotide_metabolis | 1.79277687 |
| 36 | MP0003448_altered_tumor_morphology | 1.76413845 |
| 37 | MP0006054_spinal_hemorrhage | 1.71635713 |
| 38 | MP0010155_abnormal_intestine_physiology | 1.66955184 |
| 39 | MP0005166_decreased_susceptibility_to | 1.59064437 |
| 40 | MP0002998_abnormal_bone_remodeling | 1.57726303 |
| 41 | MP0009278_abnormal_bone_marrow | 1.56972482 |
| 42 | MP0001501_abnormal_sleep_pattern | 1.45138330 |
| 43 | MP0005164_abnormal_response_to | 1.44820961 |
| 44 | * MP0000716_abnormal_immune_system | 1.40805320 |
| 45 | MP0003690_abnormal_glial_cell | 1.39991251 |
| 46 | MP0003195_calcinosis | 1.34454320 |
| 47 | MP0000858_altered_metastatic_potential | 1.34447194 |
| 48 | MP0003172_abnormal_lysosome_physiology | 1.34375024 |
| 49 | MP0003186_abnormal_redox_activity | 1.31799738 |
| 50 | MP0005167_abnormal_blood-brain_barrier | 1.30941884 |
| 51 | MP0002398_abnormal_bone_marrow | 1.30796815 |
| 52 | MP0003828_pulmonary_edema | 1.29137112 |
| 53 | MP0001851_eye_inflammation | 1.26289624 |
| 54 | MP0002138_abnormal_hepatobiliary_system | 1.25110572 |
| 55 | MP0000604_amyloidosis | 1.24913006 |
| 56 | MP0009840_abnormal_foam_cell | 1.24811280 |
| 57 | MP0005390_skeleton_phenotype | 1.21398678 |
| 58 | MP0005310_abnormal_salivary_gland | 1.16354619 |
| 59 | MP0000689_abnormal_spleen_morphology | 1.13178897 |
| 60 | MP0003300_gastrointestinal_ulcer | 1.12286931 |
| 61 | MP0008004_abnormal_stomach_pH | 1.11996316 |
| 62 | * MP0002429_abnormal_blood_cell | 1.10862290 |
| 63 | MP0003453_abnormal_keratinocyte_physiol | 1.08005454 |
| 64 | MP0001873_stomach_inflammation | 1.05100288 |
| 65 | MP0002933_joint_inflammation | 1.01849611 |
| 66 | MP0002332_abnormal_exercise_endurance | 1.00924183 |
| 67 | MP0002722_abnormal_immune_system | 1.00695051 |
| 68 | MP0009763_increased_sensitivity_to | 1.00517643 |
| 69 | MP0005397_hematopoietic_system_phenotyp | 0.99272672 |
| 70 | MP0001545_abnormal_hematopoietic_system | 0.99272672 |
| 71 | MP0002877_abnormal_melanocyte_morpholog | 0.99249682 |
| 72 | MP0004782_abnormal_surfactant_physiolog | 0.95522256 |
| 73 | MP0003646_muscle_fatigue | 0.92002428 |
| 74 | MP0003191_abnormal_cellular_cholesterol | 0.91550252 |
| 75 | MP0001542_abnormal_bone_strength | 0.91166989 |
| 76 | MP0002277_abnormal_respiratory_mucosa | 0.88706568 |
| 77 | MP0005165_increased_susceptibility_to | 0.80840431 |
| 78 | MP0000920_abnormal_myelination | 0.80792465 |
| 79 | MP0002254_reproductive_system_inflammat | 0.80159077 |
| 80 | MP0000249_abnormal_blood_vessel | 0.79328716 |
| 81 | MP0004858_abnormal_nervous_system | 0.74524967 |
| 82 | MP0005647_abnormal_sex_gland | 0.74204990 |
| 83 | MP0004883_abnormal_blood_vessel | 0.73740145 |
| 84 | MP0003329_amyloid_beta_deposits | 0.73526997 |
| 85 | MP0010352_gastrointestinal_tract_polyps | 0.71407714 |
| 86 | MP0005535_abnormal_body_temperature | 0.69932383 |
| 87 | MP0001727_abnormal_embryo_implantation | 0.69484253 |
| 88 | MP0001958_emphysema | 0.67229374 |
| 89 | MP0008874_decreased_physiological_sensi | 0.66642906 |
| 90 | MP0003795_abnormal_bone_structure | 0.66615971 |
| 91 | MP0003045_fibrosis | 0.64523925 |
| 92 | MP0003656_abnormal_erythrocyte_physiolo | 0.64000187 |
| 93 | MP0002166_altered_tumor_susceptibility | 0.62628596 |
| 94 | MP0003183_abnormal_peptide_metabolism | 0.60453386 |
| 95 | MP0002136_abnormal_kidney_physiology | 0.60381730 |
| 96 | MP0005266_abnormal_metabolism | 0.59160618 |
| 97 | MP0003091_abnormal_cell_migration | 0.58821254 |
| 98 | MP0008873_increased_physiological_sensi | 0.58350328 |
| 99 | MP0002837_dystrophic_cardiac_calcinosis | 0.56814535 |
| 100 | MP0001663_abnormal_digestive_system | 0.56215467 |
| 101 | MP0000371_diluted_coat_color | 0.55863880 |
| 102 | MP0000703_abnormal_thymus_morphology | 0.55128005 |
| 103 | MP0010307_abnormal_tumor_latency | 0.54738437 |
| 104 | MP0009765_abnormal_xenobiotic_induced | 0.53490777 |
| 105 | MP0003763_abnormal_thymus_physiology | 0.52872215 |
| 106 | MP0002693_abnormal_pancreas_physiology | 0.52844613 |
| 107 | MP0005023_abnormal_wound_healing | 0.51305974 |
| 108 | MP0004808_abnormal_hematopoietic_stem | 0.48832985 |
| 109 | MP0008260_abnormal_autophagy | 0.48494164 |
| 110 | MP0005076_abnormal_cell_differentiation | 0.47439919 |
| 111 | MP0002090_abnormal_vision | 0.46941062 |
| 112 | MP0004147_increased_porphyrin_level | 0.44892991 |
| 113 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.44870766 |
| 114 | MP0003866_abnormal_defecation | 0.44738000 |
| 115 | MP0005319_abnormal_enzyme/_coenzyme | 0.43166495 |
| 116 | MP0000465_gastrointestinal_hemorrhage | 0.42777042 |
| 117 | MP0000609_abnormal_liver_physiology | 0.42695484 |
| 118 | MP0005451_abnormal_body_composition | 0.41875309 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 7.41700963 |
| 2 | Recurrent abscess formation (HP:0002722) | 7.35399079 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 6.91993851 |
| 4 | Recurrent gram-negative bacterial infections (HP:0005420) | 6.64330080 |
| 5 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.73567161 |
| 6 | Mediastinal lymphadenopathy (HP:0100721) | 5.72953113 |
| 7 | Stomatitis (HP:0010280) | 5.72783111 |
| 8 | Systemic lupus erythematosus (HP:0002725) | 5.55675401 |
| 9 | Abnormality of macrophages (HP:0004311) | 5.34490425 |
| 10 | Orchitis (HP:0100796) | 4.51459645 |
| 11 | Autoimmune thrombocytopenia (HP:0001973) | 4.48186155 |
| 12 | Myositis (HP:0100614) | 4.35206597 |
| 13 | Optic neuritis (HP:0100653) | 4.22952163 |
| 14 | Retrobulbar optic neuritis (HP:0100654) | 4.22952163 |
| 15 | T lymphocytopenia (HP:0005403) | 4.22141753 |
| 16 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 4.20321037 |
| 17 | Axonal loss (HP:0003447) | 4.12320898 |
| 18 | Vacuolated lymphocytes (HP:0001922) | 4.11445596 |
| 19 | Increased cerebral lipofuscin (HP:0011813) | 4.10973125 |
| 20 | Recurrent skin infections (HP:0001581) | 4.08925068 |
| 21 | Gingivitis (HP:0000230) | 4.06875967 |
| 22 | Obstructive lung disease (HP:0006536) | 3.98679755 |
| 23 | Chronic obstructive pulmonary disease (HP:0006510) | 3.98679755 |
| 24 | Loss of speech (HP:0002371) | 3.78801983 |
| 25 | Nausea (HP:0002018) | 3.77452955 |
| 26 | Interstitial pulmonary disease (HP:0006530) | 3.69115259 |
| 27 | Vasculitis (HP:0002633) | 3.66324111 |
| 28 | Autoimmune hemolytic anemia (HP:0001890) | 3.64704508 |
| 29 | Basal ganglia calcification (HP:0002135) | 3.62517360 |
| 30 | Recurrent fungal infections (HP:0002841) | 3.60894102 |
| 31 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 3.60727472 |
| 32 | Nuclear cataract (HP:0100018) | 3.56271946 |
| 33 | Disinhibition (HP:0000734) | 3.53073578 |
| 34 | Mutism (HP:0002300) | 3.43765256 |
| 35 | Glomerulonephritis (HP:0000099) | 3.38029145 |
| 36 | Gangrene (HP:0100758) | 3.26577632 |
| 37 | Agnosia (HP:0010524) | 3.22224965 |
| 38 | Poor head control (HP:0002421) | 3.21844178 |
| 39 | Recurrent viral infections (HP:0004429) | 3.16344372 |
| 40 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.11166504 |
| 41 | Urticaria (HP:0001025) | 3.10160101 |
| 42 | Tetraparesis (HP:0002273) | 3.07807259 |
| 43 | Petechiae (HP:0000967) | 3.04528627 |
| 44 | Pulmonary infiltrates (HP:0002113) | 3.02880724 |
| 45 | Neurofibrillary tangles (HP:0002185) | 3.02098768 |
| 46 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.97281530 |
| 47 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.97281530 |
| 48 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.97281530 |
| 49 | Increased IgM level (HP:0003496) | 2.94270060 |
| 50 | Cellulitis (HP:0100658) | 2.86606739 |
| 51 | Abnormality of glycolipid metabolism (HP:0010969) | 2.74275716 |
| 52 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.74275716 |
| 53 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.74275716 |
| 54 | Hepatosplenomegaly (HP:0001433) | 2.67557303 |
| 55 | Thick nail (HP:0001805) | 2.65974853 |
| 56 | Purpura (HP:0000979) | 2.65135575 |
| 57 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.64812804 |
| 58 | Mucopolysacchariduria (HP:0008155) | 2.64812804 |
| 59 | Polyneuropathy (HP:0001271) | 2.64161023 |
| 60 | Periodontitis (HP:0000704) | 2.61935039 |
| 61 | Nephritis (HP:0000123) | 2.59847109 |
| 62 | Meningitis (HP:0001287) | 2.59179202 |
| 63 | IgA deficiency (HP:0002720) | 2.58865506 |
| 64 | Pustule (HP:0200039) | 2.56525400 |
| 65 | Recurrent pneumonia (HP:0006532) | 2.54513862 |
| 66 | Encephalitis (HP:0002383) | 2.54425439 |
| 67 | Recurrent cutaneous fungal infections (HP:0011370) | 2.52715769 |
| 68 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.52715769 |
| 69 | Abnormality of T cells (HP:0002843) | 2.46231268 |
| 70 | Apathy (HP:0000741) | 2.43732527 |
| 71 | Prostate neoplasm (HP:0100787) | 2.41783980 |
| 72 | Progressive neurologic deterioration (HP:0002344) | 2.40715961 |
| 73 | Keratoconjunctivitis sicca (HP:0001097) | 2.39778032 |
| 74 | Leukocytosis (HP:0001974) | 2.38812557 |
| 75 | Abnormality of the pericardium (HP:0001697) | 2.38331310 |
| 76 | Abnormality of the pleura (HP:0002103) | 2.37162885 |
| 77 | Diminished motivation (HP:0000745) | 2.36816712 |
| 78 | Dysostosis multiplex (HP:0000943) | 2.33456808 |
| 79 | Upper motor neuron abnormality (HP:0002127) | 2.32291923 |
| 80 | Arterial thrombosis (HP:0004420) | 2.30787570 |
| 81 | Joint swelling (HP:0001386) | 2.29364594 |
| 82 | Recurrent lower respiratory tract infections (HP:0002783) | 2.25674957 |
| 83 | Progressive visual loss (HP:0000529) | 2.24807768 |
| 84 | Osteomyelitis (HP:0002754) | 2.24428726 |
| 85 | Chronic diarrhea (HP:0002028) | 2.24321514 |
| 86 | Combined immunodeficiency (HP:0005387) | 2.22444186 |
| 87 | Hemoptysis (HP:0002105) | 2.20870527 |
| 88 | Zonular cataract (HP:0010920) | 2.20658005 |
| 89 | Gingival bleeding (HP:0000225) | 2.20055843 |
| 90 | Keratoconjunctivitis (HP:0001096) | 2.18489937 |
| 91 | Bone pain (HP:0002653) | 2.15444883 |
| 92 | Hypergammaglobulinemia (HP:0010702) | 2.15442057 |
| 93 | Porencephaly (HP:0002132) | 2.14747727 |
| 94 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.14480014 |
| 95 | IgG deficiency (HP:0004315) | 2.14143372 |
| 96 | Premature loss of primary teeth (HP:0006323) | 2.12554085 |
| 97 | Joint hemorrhage (HP:0005261) | 2.10595569 |
| 98 | Episodic fever (HP:0001954) | 2.09837355 |
| 99 | Hemorrhage of the eye (HP:0011885) | 2.09256376 |
| 100 | Arthralgia (HP:0002829) | 2.08820231 |
| 101 | Pulmonary embolism (HP:0002204) | 2.07363936 |
| 102 | Fused cervical vertebrae (HP:0002949) | 2.06366171 |
| 103 | Abnormality of B cell number (HP:0010975) | 2.05880763 |
| 104 | Parakeratosis (HP:0001036) | 2.05007491 |
| 105 | Metaphyseal irregularity (HP:0003025) | 2.04179052 |
| 106 | Complement deficiency (HP:0004431) | 2.03699971 |
| 107 | Pathologic fracture (HP:0002756) | 2.03033619 |
| 108 | Increased serum ferritin (HP:0003281) | 2.02961803 |
| 109 | Anorexia (HP:0002039) | 2.02257567 |
| 110 | Personality changes (HP:0000751) | 2.01583952 |
| 111 | Cerebral inclusion bodies (HP:0100314) | 2.00942216 |
| 112 | Abnormality of eosinophils (HP:0001879) | 1.99490371 |
| 113 | Recurrent bronchitis (HP:0002837) | 1.98299961 |
| 114 | Amaurosis fugax (HP:0100576) | 1.97648045 |
| 115 | Glomerulopathy (HP:0100820) | 1.97410752 |
| 116 | Esophageal neoplasm (HP:0100751) | 1.96377339 |
| 117 | Neoplasm of head and neck (HP:0012288) | 1.96377339 |
| 118 | Vertigo (HP:0002321) | 1.94244504 |
| 119 | Myocardial infarction (HP:0001658) | 1.93508388 |
| 120 | Gastrointestinal stroma tumor (HP:0100723) | 1.91566344 |
| 121 | Spontaneous hematomas (HP:0007420) | 1.91406184 |
| 122 | Prolonged neonatal jaundice (HP:0006579) | 1.90873990 |
| 123 | Gastrointestinal infarctions (HP:0005244) | 1.90272716 |
| 124 | Abnormality of T cell number (HP:0011839) | 1.86313659 |
| 125 | Chronic otitis media (HP:0000389) | 1.85542167 |
| 126 | Inappropriate behavior (HP:0000719) | 1.81894122 |
| 127 | Sepsis (HP:0100806) | 1.80515654 |
| 128 | Abnormality of iron homeostasis (HP:0011031) | 1.78099080 |
| 129 | Abnormality of complement system (HP:0005339) | 1.75855743 |
| 130 | Hematochezia (HP:0002573) | 1.75752092 |
| 131 | Peritonitis (HP:0002586) | 1.75551773 |
| 132 | Eosinophilia (HP:0001880) | 1.75077803 |
| 133 | Memory impairment (HP:0002354) | 1.74991164 |
| 134 | Vertebral compression fractures (HP:0002953) | 1.74986864 |
| 135 | Amyloidosis (HP:0011034) | 1.73475511 |
| 136 | Lower limb hyperreflexia (HP:0002395) | 1.72350542 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BLK | 4.78006491 |
| 2 | RIPK4 | 4.40288707 |
| 3 | PBK | 4.17772202 |
| 4 | MAP3K14 | 3.94974998 |
| 5 | TBK1 | 3.81610811 |
| 6 | TXK | 3.75557050 |
| 7 | ERN1 | 3.27003665 |
| 8 | IRAK3 | 2.98692343 |
| 9 | IRAK4 | 2.92640532 |
| 10 | MAP4K1 | 2.76412560 |
| 11 | DDR2 | 2.67597945 |
| 12 | IKBKB | 2.56541473 |
| 13 | IKBKE | 2.46228953 |
| 14 | TYK2 | 2.35686211 |
| 15 | JAK3 | 1.98916134 |
| 16 | NME2 | 1.93415691 |
| 17 | PIM2 | 1.88122781 |
| 18 | CSK | 1.72601832 |
| 19 | KIT | 1.70167419 |
| 20 | BMPR2 | 1.56287703 |
| 21 | FGR | 1.54291684 |
| 22 | BMX | 1.54162415 |
| 23 | GRK7 | 1.47515938 |
| 24 | ABL2 | 1.45591341 |
| 25 | ZAP70 | 1.45011286 |
| 26 | MUSK | 1.44372169 |
| 27 | MAP3K13 | 1.39958402 |
| 28 | CHUK | 1.39534914 |
| 29 | LYN | 1.39412814 |
| 30 | SYK | 1.33976705 |
| 31 | SIK3 | 1.30360468 |
| 32 | KDR | 1.29082030 |
| 33 | JAK1 | 1.27870414 |
| 34 | TYRO3 | 1.25918545 |
| 35 | MST1R | 1.25646425 |
| 36 | PRPF4B | 1.20981372 |
| 37 | HCK | 1.20200618 |
| 38 | TGFBR2 | 1.17339682 |
| 39 | TESK2 | 1.16002833 |
| 40 | ACVR1B | 1.15893995 |
| 41 | BTK | 1.14163847 |
| 42 | MATK | 1.11645538 |
| 43 | CSF1R | 1.11521903 |
| 44 | LCK | 1.11384374 |
| 45 | ADRBK2 | 1.10642800 |
| 46 | CDC42BPA | 1.04772085 |
| 47 | EIF2AK2 | 1.04466253 |
| 48 | MARK3 | 1.03717819 |
| 49 | RPS6KA4 | 1.00889179 |
| 50 | SIK2 | 0.94722925 |
| 51 | MAP3K3 | 0.93989833 |
| 52 | STK10 | 0.91467664 |
| 53 | MAP3K5 | 0.91343956 |
| 54 | FES | 0.89343885 |
| 55 | PIM1 | 0.88845768 |
| 56 | MAP2K3 | 0.86955776 |
| 57 | JAK2 | 0.84086121 |
| 58 | MAP2K6 | 0.83047892 |
| 59 | MAP3K12 | 0.77578892 |
| 60 | TEC | 0.77191372 |
| 61 | YES1 | 0.76622430 |
| 62 | PRKCD | 0.72120582 |
| 63 | IRAK2 | 0.69637287 |
| 64 | ERBB4 | 0.67423674 |
| 65 | MAP3K11 | 0.61515904 |
| 66 | NEK9 | 0.59884510 |
| 67 | ABL1 | 0.59529725 |
| 68 | ITK | 0.59170289 |
| 69 | STK4 | 0.56158927 |
| 70 | EGFR | 0.55596416 |
| 71 | MOS | 0.54754521 |
| 72 | MST4 | 0.53303084 |
| 73 | TAOK3 | 0.52225621 |
| 74 | DAPK3 | 0.51684511 |
| 75 | EPHB1 | 0.47897602 |
| 76 | CLK1 | 0.47126493 |
| 77 | ARAF | 0.45184840 |
| 78 | IRAK1 | 0.43930752 |
| 79 | SIK1 | 0.42397479 |
| 80 | CAMKK2 | 0.42231562 |
| 81 | DAPK2 | 0.39572405 |
| 82 | FYN | 0.38498641 |
| 83 | PDGFRA | 0.36752526 |
| 84 | BCKDK | 0.36187467 |
| 85 | LRRK2 | 0.35552319 |
| 86 | PRKG2 | 0.35354705 |
| 87 | PKN1 | 0.34825401 |
| 88 | IGF1R | 0.34789016 |
| 89 | LATS2 | 0.34392890 |
| 90 | ADRBK1 | 0.33223044 |
| 91 | DYRK3 | 0.29796557 |
| 92 | TRPM7 | 0.29762177 |
| 93 | TAOK2 | 0.28882855 |
| 94 | INSR | 0.28440548 |
| 95 | MAP3K1 | 0.28366913 |
| 96 | PRKCQ | 0.26297651 |
| 97 | MAPK4 | 0.25577659 |
| 98 | HIPK2 | 0.25540695 |
| 99 | MAPKAPK2 | 0.22931184 |
| 100 | ERBB3 | 0.22901666 |
| 101 | TNK2 | 0.22753296 |
| 102 | PIK3CA | 0.22663719 |
| 103 | RIPK1 | 0.21241864 |
| 104 | RPS6KA6 | 0.19383940 |
| 105 | CDK6 | 0.19286581 |
| 106 | STK3 | 0.18183172 |
| 107 | EPHA3 | 0.18165659 |
| 108 | PDK1 | 0.18057858 |
| 109 | RPS6KA1 | 0.17845004 |
| 110 | BMPR1B | 0.17340506 |
| 111 | PDPK1 | 0.17059724 |
| 112 | EIF2AK1 | 0.16911154 |
| 113 | KSR2 | 0.15975839 |
| 114 | EIF2AK3 | 0.14355611 |
| 115 | PIK3CG | 0.13928899 |
| 116 | GSK3A | 0.13818785 |
| 117 | MAPK3 | 0.13182766 |
| 118 | CDK14 | 0.12548780 |
| 119 | DYRK1B | 0.12317397 |
| 120 | PAK1 | 0.11433793 |
| 121 | SRC | 0.11404218 |
| 122 | TESK1 | 0.11222740 |
| 123 | CDK15 | 0.10127292 |
| 124 | RPS6KC1 | 0.09684207 |
| 125 | RPS6KL1 | 0.09684207 |
| 126 | TAOK1 | 0.08560423 |
| 127 | PDGFRB | 0.07686976 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Graft-versus-host disease_Homo sapiens_hsa05332 | 5.06620689 |
| 2 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 3.52475704 |
| 3 | Allograft rejection_Homo sapiens_hsa05330 | 3.50027855 |
| 4 | Leishmaniasis_Homo sapiens_hsa05140 | 3.45888766 |
| 5 | Asthma_Homo sapiens_hsa05310 | 3.28091597 |
| 6 | Legionellosis_Homo sapiens_hsa05134 | 2.97026250 |
| 7 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.88650633 |
| 8 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.84583076 |
| 9 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.77794179 |
| 10 | * Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.67886479 |
| 11 | * Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.64442269 |
| 12 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.55083379 |
| 13 | Malaria_Homo sapiens_hsa05144 | 2.53791149 |
| 14 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.50671939 |
| 15 | Pertussis_Homo sapiens_hsa05133 | 2.49067777 |
| 16 | African trypanosomiasis_Homo sapiens_hsa05143 | 2.26453254 |
| 17 | Tuberculosis_Homo sapiens_hsa05152 | 2.21063789 |
| 18 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.16781313 |
| 19 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.14211615 |
| 20 | TNF signaling pathway_Homo sapiens_hsa04668 | 2.05100419 |
| 21 | * Salmonella infection_Homo sapiens_hsa05132 | 1.97091747 |
| 22 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.85691446 |
| 23 | Measles_Homo sapiens_hsa05162 | 1.81315270 |
| 24 | Influenza A_Homo sapiens_hsa05164 | 1.66466995 |
| 25 | * Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.64172249 |
| 26 | * Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.51485347 |
| 27 | Phagosome_Homo sapiens_hsa04145 | 1.40093802 |
| 28 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.34156262 |
| 29 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.33351992 |
| 30 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.32083481 |
| 31 | Lysosome_Homo sapiens_hsa04142 | 1.27792169 |
| 32 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.21164252 |
| 33 | * Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.19427095 |
| 34 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.18590193 |
| 35 | Prion diseases_Homo sapiens_hsa05020 | 1.14836038 |
| 36 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.12899848 |
| 37 | Amoebiasis_Homo sapiens_hsa05146 | 1.12557968 |
| 38 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.07492523 |
| 39 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.02971061 |
| 40 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.98226646 |
| 41 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.97450263 |
| 42 | Shigellosis_Homo sapiens_hsa05131 | 0.96536769 |
| 43 | Apoptosis_Homo sapiens_hsa04210 | 0.90196984 |
| 44 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.88253926 |
| 45 | Other glycan degradation_Homo sapiens_hsa00511 | 0.84125247 |
| 46 | Hepatitis B_Homo sapiens_hsa05161 | 0.82418883 |
| 47 | Hepatitis C_Homo sapiens_hsa05160 | 0.80837476 |
| 48 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.79978464 |
| 49 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.78047886 |
| 50 | Bladder cancer_Homo sapiens_hsa05219 | 0.76883245 |
| 51 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.74160156 |
| 52 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.73647963 |
| 53 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.63028292 |
| 54 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.59940230 |
| 55 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.57254740 |
| 56 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.57080920 |
| 57 | Mineral absorption_Homo sapiens_hsa04978 | 0.55255022 |
| 58 | Viral myocarditis_Homo sapiens_hsa05416 | 0.53643368 |
| 59 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.53593855 |
| 60 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.53328008 |
| 61 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.53281587 |
| 62 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.50317926 |
| 63 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.50286670 |
| 64 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.50082844 |
| 65 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.45311554 |
| 66 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.38389898 |
| 67 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.35788214 |
| 68 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.35733494 |
| 69 | Platelet activation_Homo sapiens_hsa04611 | 0.33076815 |
| 70 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.32809472 |
| 71 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.32730084 |
| 72 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.32198460 |
| 73 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.31689800 |
| 74 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.30574955 |
| 75 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.28337589 |
| 76 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.26529769 |
| 77 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.22096381 |
| 78 | Proteasome_Homo sapiens_hsa03050 | 0.20768375 |
| 79 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.20750874 |
| 80 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.20518566 |
| 81 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.19303726 |
| 82 | Galactose metabolism_Homo sapiens_hsa00052 | 0.19034428 |
| 83 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.18300159 |
| 84 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.16469985 |
| 85 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.16027507 |
| 86 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.15702267 |
| 87 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.15021485 |
| 88 | Insulin resistance_Homo sapiens_hsa04931 | 0.14667470 |
| 89 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.14562115 |
| 90 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.13571259 |
| 91 | HTLV-I infection_Homo sapiens_hsa05166 | 0.11468541 |
| 92 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.10652018 |
| 93 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.09252239 |
| 94 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.08888385 |
| 95 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.08684705 |
| 96 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.07257692 |
| 97 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.06457408 |
| 98 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.04918964 |
| 99 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.04781181 |
| 100 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.03831575 |
| 101 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.03281385 |
| 102 | Endocytosis_Homo sapiens_hsa04144 | 0.01912312 |
| 103 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.01442764 |
| 104 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.01142372 |
| 105 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.01031025 |
| 106 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.00967577 |
| 107 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.00786539 |
| 108 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.00579646 |
| 109 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.00545307 |
| 110 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | -0.0334740 |
| 111 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | -0.0229992 |
| 112 | Notch signaling pathway_Homo sapiens_hsa04330 | -0.0220899 |
| 113 | FoxO signaling pathway_Homo sapiens_hsa04068 | -0.0099199 |
| 114 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | -0.0031045 |

